Non-coding DNA variants for risk in lupus.

[1]  Xianjun Yu,et al.  Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets , 2023, Signal transduction and targeted therapy.

[2]  L. Looger,et al.  Genome-wide association study for systemic lupus erythematosus in an egyptian population , 2022, Frontiers in Genetics.

[3]  Yongfei Wang,et al.  Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus , 2022, Arthritis & rheumatology.

[4]  Q. Lu,et al.  Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study , 2022, Annals of the Rheumatic Diseases.

[5]  M. Weirauch,et al.  Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery , 2022, Nature Communications.

[6]  Y. Lau,et al.  Identification of Shared and Asian‐Specific Loci for Systemic Lupus Erythematosus and Evidence for Roles of Type III Interferon Signaling and Lysosomal Function in the Disease: A Multi‐Ancestral Genome‐Wide Association Study , 2021, Arthritis & rheumatology.

[7]  A. Reinisch,et al.  Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi , 2021, Genome research.

[8]  P. Gaffney,et al.  Variants on the UBE2L3/YDJC Autoimmune Disease Risk Haplotype Increase UBE2L3 Expression by Modulating CCCTC‐Binding Factor and YY1 Binding , 2021, Arthritis & rheumatology.

[9]  Ryan M. Layer,et al.  A complete reference genome improves analysis of human genetic variation , 2021, bioRxiv.

[10]  Nathan S. Abell,et al.  Multiple Causal Variants Underlie Genetic Associations in Humans , 2021, bioRxiv.

[11]  L. Looger,et al.  Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis , 2021, Arthritis & rheumatology.

[12]  Y. Okada,et al.  Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases , 2021, Cell.

[13]  Daniel E. Miller,et al.  Global discovery of lupus genetic risk variant allelic enhancer activity , 2021, Nature Communications.

[14]  Jiangshan J. Shen,et al.  Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups , 2021, Nature Communications.

[15]  Y. Lau,et al.  Genome-wide association study on Northern Chinese identifies KLF2, DOT1L and STAB2 associated with systemic lupus erythematosus. , 2021, Rheumatology.

[16]  David K. Yang,et al.  Genome-wide functional screen of 3′UTR variants uncovers causal variants for human disease and evolution , 2021, Cell.

[17]  Amanda M Li,et al.  CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. , 2020, The New England journal of medicine.

[18]  M. Weirauch,et al.  Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus , 2020, Annals of the Rheumatic Diseases.

[19]  Dmitry D. Penzar,et al.  Landscape of allele-specific transcription factor binding in the human genome , 2020, Nature Communications.

[20]  Jay Shendure,et al.  A systematic evaluation of the design and context dependencies of massively parallel reporter assays , 2020, Nature Methods.

[21]  Xuejun Zhang,et al.  Independent Replication on Genome-Wide Association Study Signals Identifies IRF3 as a Novel Locus for Systemic Lupus Erythematosus , 2020, Frontiers in Genetics.

[22]  M. Weirauch,et al.  SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression , 2020, bioRxiv.

[23]  Carl G. de Boer,et al.  Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features , 2020, Nature Communications.

[24]  A. Pombo,et al.  Methods for mapping 3D chromosome architecture , 2019, Nature Reviews Genetics.

[25]  P. Gaffney,et al.  Role of Systemic Lupus Erythematosus Risk Variants With Opposing Functional Effects as a Driver of Hypomorphic Expression of TNIP1 and Other Genes Within a Three‐Dimensional Chromatin Network , 2019, Arthritis & rheumatology.

[26]  B. Liu,et al.  Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing , 2019, bioRxiv.

[27]  D. Absher,et al.  Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus , 2018, Arthritis Research & Therapy.

[28]  X. Zuo,et al.  Genome‐wide association study identifies three novel susceptibility loci for systemic lupus erythematosus in Han Chinese , 2018, The British journal of dermatology.

[29]  Matthew C. Canver,et al.  High-Throughput Approaches to Pinpoint Function within the Noncoding Genome. , 2017, Molecular cell.

[30]  P. Gregersen,et al.  Transancestral mapping and genetic load in systemic lupus erythematosus , 2017, Nature Communications.

[31]  Jianzhong Su,et al.  Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein , 2017, Nature Communications.

[32]  Yang I Li,et al.  An Expanded View of Complex Traits: From Polygenic to Omnigenic , 2017, Cell.

[33]  Giacomo Cavalli,et al.  Organization and function of the 3D genome , 2016, Nature Reviews Genetics.

[34]  P. Gaffney,et al.  Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus , 2016, Nature Genetics.

[35]  Y. J. Kim,et al.  High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry , 2016, Nature Genetics.

[36]  P. Gaffney,et al.  Identification of a New Susceptibility Locus for Systemic Lupus Erythematosus on Chromosome 12 in Individuals of European Ancestry , 2016, Arthritis & rheumatology.

[37]  P. Gaffney,et al.  Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans , 2015, Arthritis & rheumatology.

[38]  P. Gaffney,et al.  Genome‐Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture , 2015, Arthritis & rheumatology.

[39]  J. Rioux,et al.  Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus , 2015, Nature Genetics.

[40]  Eytan Zlotorynski.  Plant development: A fruit-bearing microRNA , 2015, Nature Reviews Molecular Cell Biology.

[41]  Jiangshan J. Shen,et al.  Genome-wide search followed by replication reveals genetic interaction of CD80 and ALOX5AP associated with systemic lupus erythematosus in Asian populations , 2015, Annals of the rheumatic diseases.

[42]  R. Maehr,et al.  Functional annotation of native enhancers with a Cas9 -histone demethylase fusion , 2015, Nature Methods.

[43]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[44]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[45]  Bjoern Peters,et al.  Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility , 2014, Nature Immunology.

[46]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[47]  P. Gaffney,et al.  An Enhancer Element Harboring Variants Associated with Systemic Lupus Erythematosus Engages the TNFAIP3 Promoter to Influence A20 Expression , 2013, PLoS genetics.

[48]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[49]  H. Lähdesmäki,et al.  Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization. , 2013, Immunity.

[50]  E. Dermitzakis,et al.  Expression quantitative trait loci: present and future , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[51]  Luke A. Gilbert,et al.  Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.

[52]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[53]  P. Sham,et al.  Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. , 2013, American journal of human genetics.

[54]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[55]  James B. Brown,et al.  Modeling gene expression using chromatin features in various cellular contexts , 2012, Genome Biology.

[56]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[57]  P. Gaffney,et al.  Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. , 2012, American journal of human genetics.

[58]  Y. Okada,et al.  A Genome-Wide Association Study Identified AFF1 as a Susceptibility Locus for Systemic Lupus Eyrthematosus in Japanese , 2012, PLoS genetics.

[59]  A. Syvänen,et al.  Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus , 2011, PLoS genetics.

[60]  Nan Shen,et al.  A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus , 2011, PLoS genetics.

[61]  Liangdan Sun,et al.  Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. , 2011, Rheumatology.

[62]  Annette Lee,et al.  Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production , 2011, PLoS genetics.

[63]  P. Sham,et al.  Two missense variants in UHRF1BP1 are independently associated with systemic lupus erythematosus in Hong Kong Chinese , 2011, Genes and Immunity.

[64]  P. Sham,et al.  ELF1 is associated with systemic lupus erythematosus in Asian populations. , 2011, Human molecular genetics.

[65]  Liangdan Sun,et al.  Polymorphisms at 16p13 are associated with systemic lupus erythematosus in the Chinese population , 2010, Journal of Medical Genetics.

[66]  P. Visscher,et al.  Common SNPs explain a large proportion of the heritability for human height , 2010, Nature Genetics.

[67]  P. Sham,et al.  Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus , 2010, PLoS genetics.

[68]  Annette Lee,et al.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus , 2009, Nature Genetics.

[69]  Ying Wang,et al.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.

[70]  P. Park.  ChIP–seq: advantages and challenges of a maturing technology , 2009, Nature Reviews Genetics.

[71]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[72]  M. Daly,et al.  Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[73]  Geoffrey Hom,et al.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.

[74]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[75]  Sandra D'Alfonso,et al.  Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[76]  L. Hellman,et al.  Electrophoretic mobility shift assay (EMSA) for detecting protein–nucleic acid interactions , 2007, Nature Protocols.

[77]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[78]  Marta E Alarcón-Riquelme,et al.  Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. , 2005, Arthritis and rheumatism.

[79]  Glinda S Cooper,et al.  Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. , 2002, Journal of clinical epidemiology.

[80]  J. Dekker,et al.  Capturing Chromosome Conformation , 2002, Science.

[81]  T. Mack,et al.  A revised estimate of twin concordance in systemic lupus erythematosus. , 1992, Arthritis and rheumatism.

[82]  J. Kaprio,et al.  Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features , 1992, Journal of internal medicine.

[83]  F. Arnett,et al.  STUDIES IN FAMILIAL SYSTEMIC LUPUS ERYTHEMATOSUS , 1976, Medicine.

[84]  M. Lockshin,et al.  Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. , 1975, The American journal of medicine.

[85]  T. Leonhardt.  FAMILIAL HYPERGAMMAGLOBULINÆMIA AND SYSTEMIC LUPUS ERYTHEMATOSUS , 1957 .

[86]  M. Allende.  Lupus erythematosus, discoid and systemic: one disease. , 1956, Postgraduate medicine.

[87]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.